Visit Saratoga.com For Everything Saratoga
Enter Giveaways Advertise
Note: Saratoga.com is not responsible for posts and comments written by non-staff members.
Home  »  Uncategorized  »  Let’s Talk About PAPs, Baby!
Uncategorized

Let’s Talk About PAPs, Baby!

Posted on

On my homepage, I discussed the facts on PAPs, so make sure
you go to my homepage at dr-lobisco.com to review the overview.

Now, what about the vaccination?

In the United States there are currently two available vaccinations
recommended by Centers for Disease Control and Prevention (CDC) and licensed by
the FDA (Food and Drug Administration) for Human Papilloma Virus (HPV): Cervarix
(made by GlaxoSmithKline) and Gardasil (made by Merck).

Facts on the Vacs:

·Both provide immunological activity (containing
the protein outer coat for stimulation) aimed toward 2 of the 40 types of HPV
associated with cervical cancer, types 16 and 18.

·Both Vaccines require 3 shots

·Gardisal:

o provides immunological activity for 2
additional HPV types, 6 and 11, the serotypes of HPV usually associated with genital
warts

o is
the only vaccination licensed for use in males

o has
been tested and has some evidence of protection for precancerous cells of the genitals
other than cervical

·Both vaccines contain adjuvant, chemicals added
to the vaccine to increase the body’s immune response

·Most HPV infections clear by themselves within
two years

·The CDC feels the vaccinations are safe

Source:

Center for Disease Control and Prevention. HPV Vaccine:
Questions and Answers. Updated 2011. http://www.cdc.gov/vaccines/vpd-vac/hpv/vac-faqs.htm

Is the Vaccine Safe?

 

The CDC-FDA summary of data on safety from reviewing the
Vaccine Adverse Event Report System (VAERS) from 2006-2009 reports the
following:

The study’s main
findings include the following:

  • “More
    than 23 million doses were administered nationally since the HPV vaccine
    was licensed in June 2006. There were a total of 12,424 reports to VAERS
    of adverse events following HPV vaccination through December 2008.”
    (Please note that only 12000 cases of HPV associated cervical cancers are
    reported per year).
  • “94% of
    adverse events reported to VAERS after receiving this vaccine have not
    been serious.
  • The
    most common events reported were:

    • Syncope
      (or fainting)-common after need injections, especially in pre-teens and
      teens
    • Local
      reactions at the site of immunization (pain and redness)
    • Dizziness
    • Nausea
    • Headache
  • “Of
    the 12,424 reports of adverse events, 772 (6% of all reports) described
    serious adverse events, including 32 reports of deaths.
  • “The
    32 death reports were reviewed and there was no common pattern to the
    deaths that would suggest they were caused by the vaccine. In cases where
    there was an autopsy, death certificate, or medical records, the cause of death
    could be explained by factors other than the vaccine. Some causes of death
    determined to date include diabetes, viral illness, illicit drug use, and
    heart failure.”
  • There
    were two reports of a connection currently being studied between Amytrophic
    Lateral Sclerosis (ALS) often referred to as “Lou Gehrig’s Disease”) that
    resulted in the death of two young females by researchers.
  • There
    was an association of higher reports of syncope (fainting) and pulmonary
    emboli (blood clots of the lungs) compared with what has been found for
    other vaccines given to females of the same age.

The National Vaccine
Information Center (NVIC) suggests an underreporting of serious adverse
events and has asked the CDC to continue to evaluate safety related to:

  • Guillain-Barré
    Syndrome (GBS)
  • Blood
    Clots
  • Death

Some may be sensitive to the adjuvants added to the
vaccination including:

  1. Aluminum
    adjuvants
  2. Polysorbate
    80, which has been linked to infertility in mice.
  3. Sodium
    borate, a main ingredient in roach killer.

Sources:

Centers for Disease Control and Prevention. Summary of HPV
Adverse Event Reports Published in JAMA. Updated February 2011. http://www.cdc.gov/vaccinesafety/Vaccines/HPV/jama.html

PressWire.NVIC Analysis Shows Greater Risk of GBS Reports
When HPV Vaccine Is Given with Meningococcal and Other Vaccines. NVIC source.
March 2007. Accessed July 6, 2012. http://www.prnewswire.com/news-releases/nvic-analysis-shows-greater-risk-of-gbs-reports-when-hpv-vaccine-is-given-with-meningococcal-and-other-vaccines-58225822.html

Merck. USPPI Patient Information about GARDASIL® (pronounced
“gard-Ah-sill”) Generic name: [Human Papillomavirus Quadrivalent (Types 6, 11,
16, and 18) Vaccine, Recombinant]. 2011. http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_ppi.pdf

Related Posts